Evidence map›Paper›PMID 27385375›Full record

ArticleJournal of proteomics2016

Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.

Scott M Gordon, Hailong Li, Xiaoting Zhu, Patrick Tso, Catherine A Reardon, Amy S Shah, L Jason Lu, W Sean Davidson

Open access · greenAbstract read
In one paragraph

Article in Journal of proteomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Scott M GordonCenter for Lipid and Arteriosclerosis Science, Department of Pathology and Laboratory Medicine, University of Cincinnati, 2120 East Galbraith Road, Cincinnati, OH 45237-0507, USA. Electronic address: Scott.Gordon@nih.gov.
Hailong LiDivision of Biomedical Informatics, Cincinnati Children's Hospital Research Foundation, 3333 Burnet Avenue, MLC 7024, Cincinnati, OH 45229-3039, USA. Electronic address: hailong.li@cchmc.org.
Xiaoting ZhuDivision of Biomedical Informatics, Cincinnati Children's Hospital Research Foundation, 3333 Burnet Avenue, MLC 7024, Cincinnati, OH 45229-3039, USA. Electronic address: xiaoting.zhu@cchmc.org.
Patrick TsoCenter for Lipid and Arteriosclerosis Science, Department of Pathology and Laboratory Medicine, University of Cincinnati, 2120 East Galbraith Road, Cincinnati, OH 45237-0507, USA. Electronic address: Patrick.Tso@uc.edu.
Catherine A ReardonDepartment of Pathology, University of Chicago, Chicago, IL 60637, USA. Electronic address: reardon@uchicago.edu.
Amy S ShahDepartment of Pediatrics, Cincinnati Children's Hospital Research Foundation, 3333 Burnet Avenue, MLC 7012, Cincinnati, OH 45229-3039, USA. Electronic address: Amy.Shah@cchmc.org.
L Jason LuDivision of Biomedical Informatics, Cincinnati Children's Hospital Research Foundation, 3333 Burnet Avenue, MLC 7024, Cincinnati, OH 45229-3039, USA. Electronic address: long.lu@cchmc.org.
W Sean DavidsonCenter for Lipid and Arteriosclerosis Science, Department of Pathology and Laboratory Medicine, University of Cincinnati, 2120 East Galbraith Road, Cincinnati, OH 45237-0507, USA. Electronic address: Sean.Davidson@uc.edu.
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · USUniversity of Chicago · US

Funding

LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Apolipoprotein A-I structure in high density lipoproteinsR01HL067093 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 2002 to 2016
$4.3M
A Network-based Approach to Associate HDL Subspeciation with FunctionR01HL111829 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI LU, LONG · 2012 to 2016
$2.6M
APOLIPOPROTEIN-MEDIATED CHOLESTEROL EFFLUXR01HL062542 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 1999 to 2008
$2.2M
Understanding the Role of HDL Subspecies in Adolescents with Type 2 DiabetesK23HL118132 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SHAH, AMY SANGHAVI · 2014 to 2018
$855k
The molecular basis for high density lipoprotein heterogeneityR21HL104136 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 2010 to 2011
$440k
NCATS NIH HHS UL1 TR001425NHLBI NIH HHS K23 HL118132NHLBI NIH HHS R01 HL062542NHLBI NIH HHS R01 HL067093NHLBI NIH HHS R01 HL111829NHLBI NIH HHS R21 HL104136
6 · The paper itself

Abstract

unlabelledGiven their association with cardiovascular disease protection, there has been intense interest in understanding the biology of high density lipoproteins (HDL). HDL is actually a family of diverse particle types, each made up of discrete - but as yet undetermined - combinations of proteins drawn from up to 95 lipophilic plasma proteins. The abundant apolipoproteins (apo) of the A class (apoA-I, apoA-II and apoA-IV) have been proposed to act as organizing platforms for auxiliary proteins, but this concept has not been systematically evaluated. We assessed the impact of genetic knock down of each platform protein on the particle size distribution of auxiliary HDL proteins. Loss of apoA-I or apoA-II massively reduced HDL lipids and changed the plasma size pattern and/or abundance of several plasma proteins. Surprisingly though, many HDL proteins were not affected, suggesting they assemble on lipid particles in the absence of apoA-I or apoA-II. In contrast, apoA-IV ablation had minor effects on plasma lipids and proteins, suggesting that it forms particles that largely exclude other apolipoproteins. Overall, the data indicate that distinct HDL subpopulations exist that do not contain, nor depend on, apoA-I, apoA-II or apoA-IV and these contribute substantially to the proteomic diversity of HDL. BIOLOGICAL SIGNIFICANCE: Plasma levels of high density lipoproteins (HDL) are inversely correlated with cardiovascular disease. These particles are becoming known as highly heterogeneous entities that have diverse compositions and functions that may impact disease. Unfortunately, we know little about the forces that maintain the composition of each particle in plasma. It has been suggested that certain 'scaffold' proteins, such as apolipoprotein (apo) A-I, apoA-II and apoA-IV, may act as organizing centers for the docking of myriad accessory proteins. To test this hypothesis, we took advantage of the genetic tractability of the mouse model and ablated these three proteins individually. We then tracked the abundance and size profile of the remaining HDL proteins by gel filtration chromatography combined with mass spectrometry. The results clearly show that certain cohorts of proteins depend on each scaffold molecule to assemble normal sized HDL particles under wild-type conditions. This work forms the basis for more detailed studies that will define the specific compositions of HDL subspecies with the possibility of connecting them to specific functions or roles in disease.

Indexed as

Gene DeletionAnimalsApolipoprotein A-IApolipoprotein A-IIApolipoproteinsApolipoproteins AChromatography, GelLipoproteins, HDLMass SpectrometryMiceParticle SizeProteomicsApolipoprotein A-IApolipoprotein A-IIapolipoprotein A-IVApolipoproteinsApolipoproteins ALipoproteins, HDLApolipoproteinHigh density lipoproteinLipoproteinMass spectrometryMouse modelProteomics

Identifiers

PMID27385375
PMCPMC4987197
OpenAlexW2475116508

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.